amifostine anhydrous and epoetin alfa

amifostine anhydrous has been researched along with epoetin alfa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, KH; Han, HS; Han, JY; Kim, HT; Kim, HY; Lee, DH; Lee, JS; Pyo, HR; Yu, SY	1

Trials

1 trial(s) available for amifostine anhydrous and epoetin alfa

Article	Year
Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer. Cancer, 2008, Oct-01, Volume: 113, Issue:7 Topics: Aged; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Female; Humans; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Radiation-Protective Agents; Recombinant Proteins; Survival Analysis	2008

Article

Year

Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.

Cancer, 2008, Oct-01, Volume: 113, Issue:7

Topics: Aged; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Epoetin Alfa; Erythropoietin; Female; Humans; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Radiation-Protective Agents; Recombinant Proteins; Survival Analysis

2008